Our strategic feasibility planning is distinguished by its precision and depth. Leveraging decades of global clinical research acumen and an expansive investigator network, we employ predictive data modeling to craft bespoke feasibility studies that extend well beyond traditional investigator questionnaires. This sophisticated methodology is meticulously engineered to synchronize with sponsor timelines, harmonize country-specific regulatory requirements, and delineate an expedited pathway to regulatory approval.
In alignment with the best practices of leading organizations such as WCG Clinical and Citeline, our feasibility experts systematically analyze historical site performance, harness predictive analytics, and incorporate real-world patient access data. This ensures not only a reduction in trial startup times but also the optimization of site selection strategies—key determinants of success in both early and late-phase clinical trials, including Phase 1 clinical trial services in India, Global Phase 2 clinical trial management, and Phase 3 clinical trial support for pharma companies.
Our feasibility offerings are architected upon seven critical pillars, each contributing a robust, data-driven foundation for clinical trial execution:
This multi-faceted framework ensures that your clinical trial remains not only on schedule but also within budgetary parameters, regardless of complexity or scale. Eschewing static and antiquated feasibility models, ProRelix Research adopts a dynamic, iterative methodology underpinned by data science.
We integrate epidemiological databases, electronic medical record (EMR) insights, patient population analytics, and key performance indicators from past site performance to construct a comprehensive, 360-degree perspective of clinical potential. This approach resonates with the philosophies of IQVIA and Precision for Medicine, where predictive site performance modeling, machine learning algorithms, and real-time enrollment tracking are harnessed to yield actionable feasibility insights.
Our data-driven strategies empower sponsors to:
With a global footprint and a distinguished investigator network, ProRelix Research is adept at orchestrating complex, multi-regional studies. Our expertise encompasses a diverse array of therapeutic areas and regulatory landscapes, ensuring seamless compliance with local and international standards. Whether supporting herbal clinical trial CRO in India, executing bioequivalence studies as per USFDA guidelines, or delivering personalized medicine clinical trials, our feasibility services are tailored to the nuanced requirements of each project.
Our medical writing services are designed to seamlessly integrate with your clinical and regulatory strategies, ensuring that every word we write propels your product forward in a scientifically robust and globally compliant manner.
Our feasibility assessments are further fortified by robust clinical data management outsourcing and biostatistics services for clinical trials, ensuring that all projections are grounded in precise data capture and rigorous statistical analysis. Additionally, our regulatory medical writing services provide comprehensive support for clinical study protocols, investigator brochures, and regulatory submissions.
Entrust your clinical development journey to ProRelix Research and experience the transformative impact of sophisticated feasibility services. From Phase 1 to Phase 4 and beyond, our strategic, data-driven approach ensures your trial is positioned for success in an increasingly complex and competitive landscape.
In the dynamic and highly regulated world of clinical research, selecting the right investigational sites is one of the most critical elements in ensuring the success of a clinical trial. Site selection directly influences patient recruitment, data quality, regulatory compliance, and, ultimately, the integrity and reliability of the trial results. We recognize the importance of meticulous site selection and employ a rigorous, data-driven approach to ensure that every trial site we choose meets the highest standards of excellence and capability. This approach is fundamental to the success of our Clinical Trial Services (Phase I-IV), which span the entire clinical trial process.
ProRelix Research’s site selection strategy is grounded in four core principles that ensure the seamless execution of clinical trials from initiation to conclusion: Predictability, Enrollment, Retention, and Data Quality. These principles not only guide our site selection process but also differentiate us as a leading CRO for early and late phase clinical trials with an unwavering commitment to delivering on time, on budget, and with the highest level of integrity.
One of the biggest challenges in clinical trials is the unpredictable nature of patient enrollment. We believe that predictability in enrollment is paramount to maintaining the trial timeline and ensuring efficient resource allocation. A site’s history of accurately predicting its patient enrollment capabilities is a key criterion for site selection.
We work with sites that have demonstrated a consistent ability to forecast the recruitment rate of patients based on historical data and prior performance in similar studies. Predictability is crucial in mitigating delays and uncertainties in clinical trials.
With our deep understanding of trial dynamics, regulatory requirements, and patient needs, we collaborate closely with investigational sites during the feasibility stage to ensure they have a clear plan in place for recruitment, based on their understanding of local demographics, disease prevalence, and logistical considerations.
This is why we emphasize selecting sites that align with our Phase 1 clinical trial services in USA and India, where successful patient recruitment is essential.By leveraging ProRelix Research’s comprehensive experience and strategic partnerships, we ensure that the sites we select are well-equipped to handle the challenges of patient enrollment and can deliver on the set timelines with minimal risk of delays.
Predictability goes beyond merely meeting patient enrollment numbers; it also involves assessing the efficiency of the site’s operations, including the speed at which they can process screenings, perform assessments, and obtain necessary documentation. Through this meticulous evaluation, we provide our clients with the assurance that enrollment targets will be met.
Successful patient enrollment is the cornerstone of any clinical trial. Without sufficient patient enrollment, a trial cannot proceed, and its outcomes will be compromised. We take patient recruitment seriously, and we only work with sites that have a proven track record of enrolling the required number of patients within specified timelines.
Our approach to enrollment begins at the feasibility stage, where we work closely with our network of investigational sites to determine their capacity for patient recruitment. We assess factors such as the site’s experience in recruiting similar patient populations, their familiarity with the study protocol, and their access to the right patient demographics. Additionally, we consider the site’s ability to maintain engagement with the patient population over time, ensuring that the study can reach its enrollment target without compromising on quality.
This approach aligns with our Global Phase 2 clinical trial management expertise, where precise enrollment planning is key to the study’s success.ProRelix Research goes beyond simply looking at the enrollment history of a site. We employ a proactive approach to assess whether the site’s recruitment strategy is aligned with the study’s needs and goals. This includes evaluating patient screening procedures, recruitment strategies, and the site’s ability to access potential participants through targeted advertising, physician networks, or patient registries.
Once a site has been selected based on its enrollment capabilities, We works closely with the site team to ensure that the recruitment process continues to move smoothly throughout the study. We monitor the progress of patient enrollment in real-time and make adjustments as necessary to meet enrollment milestones and keep the study on track. Our dedication to proactive monitoring ensures that any issues with recruitment are addressed quickly and efficiently, ensuring that the trial progresses as planned.
Retaining patients throughout the clinical trial is just as critical as recruiting them. Patient retention can be impacted by various factors, including the burden of trial procedures, patient satisfaction, and logistical challenges. We prioritize patient retention by selecting sites with a history of successfully maintaining patient engagement and satisfaction.
The staff and operational procedures at an investigational site must be diligent and professional to ensure that patients remain committed to the study throughout its duration. We work with sites that have well-established processes for patient communication, follow-ups, and support, ensuring that patients feel valued and supported at every stage of the trial.
Our approach to patient retention also involves ensuring that the site has the necessary resources and infrastructure to manage patient visits effectively. Sites must be able to accommodate patient needs, such as scheduling flexibility, transportation assistance, and clear communication about study procedures and expectations. A site’s commitment to patient-centric care is a significant factor in our site selection process.
ProRelix Research works closely with sites to ensure that patient engagement strategies are in place and continuously evaluated.This includes ongoing monitoring of patient visits, satisfaction surveys, and direct communication with patients to identify potential concerns before they lead to dropout. By focusing on patient retention, we ensure that trials are completed on time and that data integrity is preserved.
In clinical trials, the quality of the data collected is the foundation upon which conclusions are drawn. High-quality data is essential for regulatory approval, as well as for ensuring the safety and efficacy of the investigational product. At ProRelix Research, we are committed to ensuring that every site we select meets the highest standards of data quality, ensuring that all trial results are reliable, reproducible, and consistent.
We evaluate a site’s ability to generate high-quality data by assessing its experience with data collection, data management systems, and adherence to Good Clinical Practice (GCP) guidelines. Sites must have the necessary expertise to handle complex data collection methods and ensure that all data is accurately recorded, securely stored, and processed according to regulatory standards.
ProRelix Research’s close working relationship with investigational sites ensures that they are fully trained on the protocol requirements, GCP standards, and regulatory guidelines that govern data collection and reporting. We also conduct regular audits and site visits to verify data accuracy, address any discrepancies, and ensure that the site is following proper procedures.
Furthermore, we ensure that sites are equipped with the necessary technology and tools to facilitate efficient and accurate data collection. This includes the use of electronic data capture (EDC) systems, electronic medical records (EMR), and other advanced tools that streamline the data collection process and reduce the risk of errors.
Beyond site selection, ProRelix Research provides ongoing monitoring and support to ensure that sites consistently meet performance expectations. Our monitoring systems include real-time tracking of key performance indicators (KPIs) such as recruitment rates, data accuracy, patient compliance, and protocol adherence.
By regularly assessing these metrics, we can proactively address issues before they escalate and implement corrective actions when necessary.Additionally, our team of dedicated clinical research associates (CRAs) works closely with site staff to foster a collaborative environment that prioritizes continuous improvement.
This partnership ensures that any challenges encountered during the trial are swiftly addressed, while maintaining focus on achieving the trial objectives within the required timelines.We believe that collaboration is key to a successful clinical trial. Our expert CRAs, along with site staff, share knowledge and expertise to ensure best practices are consistently followed, contributing to the successful completion of each trial.
ProRelix Research’s involvement in site selection extends far beyond the initial selection process. From the feasibility stage through to database lock, we remain an integral partner in the trial’s success. At the outset, our team works closely with the site to identify prospective patients, establish realistic recruitment goals, and align on timelines. By setting these expectations early, we eliminate uncertainty and ensure a transparent and efficient recruitment process.
Throughout the course of the trial, we maintain close communication with the sites to track progress, address issues, and offer guidance when necessary. Whether it’s providing additional resources to improve patient retention or ensuring data quality remains uncompromised, ProRelix Research is committed to supporting the investigational sites at every stage.
This hands-on approach continues until the final database lock, ensuring that all data is complete, accurate, and compliant with regulatory standards. Our commitment to excellence in data quality guarantees that the trial’s outcomes are valid and ready for analysis, paving the way for successful regulatory submissions and real-world application.
If you are seeking comprehensive CRO for early and late phase clinical trials,We can provide you with the expertise and resources necessary to ensure that your clinical trial progresses smoothly and meets its targets. Our experience spans across Global Phase 2 clinical trial management and beyond, ensuring that we are the trusted partner for your clinical research needs.
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.